CASI Pharmaceuticals
CASI
CASI
54 hedge funds and large institutions have $45.9M invested in CASI Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
14% less funds holding
Funds holding: 63 → 54 (-9)
75% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 12
Holders
54
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.16M | |
| 2 | +$1.13M | |
| 3 | +$742K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$305K |
| 5 |
AA
ALPS Advisors
Denver,
Colorado
|
+$269K |
Top Sellers
| 1 | -$368K | |
| 2 | -$222K | |
| 3 | -$204K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$192K |
| 5 |
Barclays
London,
United Kingdom
|
-$110K |